These results suggested that a high expression of EPB41L5 play a central role in the poor outcome of breast cancer patients, rather than high expression of the other EMT-related genes, including ZEB1. In this regard, it should be noted that the EPB41L5 gene is not the sole target of ZEB1. The gene discussed is ZEB1; the disease is breast cancer.